Santa Barbara Medical Innovations Sponsors 2009 Microsoft Alumni Foundation Integral Fellows Awar... (d Chip Conk CEO of SBMI. “The numb...)

Santa Barbara Medical Innovations Sponsors 2009 Microsoft Alumni Foundation Integral Fellows Awards Program

Date:11/17/2009

d Chip Conk, CEO of SBMI. “The number of physicians and top-tier medical spas that are offering ZERONA® is expanding greatly every month.”

ZERONA® utilizes the Erchonia® Laser Scanner, the safest and most researched low-level laser in the world. Initially designed and FDA approved for use during liposuction, the non-invasive laser is applied to emulsify the adipose (fatty) tissue and release excess fat into the interstitial space (the space between the fat cells). From there, fat is passed through the body during its normal course of detoxification.

Rowland Hanson, Chairman of SBMI says that the company will soon commence distribution of Erchonia® low level lasers for elimination of pain, treatment of acne and to promote rapid healing of wounds without the use of drugs. Today, thousands of healthcare professionals worldwide are using Erchonia® lasers for a variety of applications.

About Santa Barbara Medical Innovations:
SBMI is dedicated to bringing clinically proven, innovative health and wellness products that are safe and effective to market. SBMI is the exclusive North American distributor of ZERONA® the only clinically proven, non-invasive body slimming device on the market. For more information, visit www.SBMI.com

About the Manufacturer:
Erchonia® is the global leader in low-level laser healthcare applications. Over the last 15 years Erchonia has been conducting research & development with the world's leading physicians to advance the science of low-level lasers. Prior to market introduction, all Erchonia lasers are proven to be safe and effective through independent clinical trials. Currently thousands of Erchonia's lasers are used daily to reduce body fat, eliminate pain, accelerate healing and treat acne. For more information, visit

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Leeza Gibbons & Santa Barbara Medical Innovations Launch Ambitious Campaign to Educate & Slim America Down with ZERONA(R).
2. $3.5 million NIH grant supports AIDS vaccine research at UC Santa Cruz
3. MTF, Largest Tissue Bank, Provides Skin for Victims of Santa Barbara Wildfires
4. Anthem Blue Cross to Support Members and Communities Impacted by Santa Barbara Fires
5. Santarus to Webcast Analyst Day and Investor Briefing Presentation on May 13
6. Dr. Khanna Supports a Taste of Town in Santa Clarita
7. Ocean Cosmetic Medicine of Santa Monica Has Created Something New: Personalized Boutique Style Aesthetic Treatments
8. Santa Monica Media Corporation Files Extension Proxy With SEC to Complete Transaction
9. Steve Teal, Santa Rosa Attorney, Obtains $850,000 for Client in Highest Hospital Negligence Verdict in Mendocino County
10. Biotest Pharmaceuticals Corporation Acquires Santa Fe, New Mexico Plasmapheresis Center
11. The SCAN Foundation Funds New Program for Santa Clarita and South Los Angeles Seniors and Those Who Care for Them

Post Your Comments:

(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...

(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...

(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...

(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...

(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...

Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2 Health News:New Jersey Kids 'Kick Butts' on March 24 3 Health News:New Jersey Kids 'Kick Butts' on March 24 4 Health News:New Jersey Kids 'Kick Butts' on March 24 5 Health News:New Hampshire Kids 'Kick Butts' on March 24 2 Health News:New Hampshire Kids 'Kick Butts' on March 24 3 Health News:New Hampshire Kids 'Kick Butts' on March 24 4 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5 Health News:Residency match results not encouraging for adults needing primary care 2 Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2 Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3

[0] New Jersey Kids 'Kick Butts' on March 24 [0] New Hampshire Kids 'Kick Butts' on March 24 [0] Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco [0] Residency match results not encouraging for adults needing primary care [0] Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years

... prescription drugs with hydrocodone could be involved , , ... announced Friday a crackdown on drug companies that make ... used as a cough suppressant and pain killer. ... to treat pain or to suppress cough. It,s also ...

... ... Percent Revenue Growth, ATLANTA, Sept. 28 For the third year ... has been named to Deloitte,s prestigious Technology Fast,50 program for Georgia. SecureWorks ... and has ranked in the top ten,for the past three years. ...

... the lives of patients who have suffered a stroke and ... on bmj.com today. , Stroke is the second ... cause of serious, long-term disability in adults. Six months ... others to help them carry out everyday tasks such as ...

... unveiled plans for a $100 million initiative to create ... problems in the developing world, such as HIV/AIDS and ... annual meeting of the Clinton Global Initiative in New ... Health," the initiative will focus on both research and ...

... LLC, a clinical-stage drug development company,commercializing first-in-class drugs ... diffusion, today announced the results of a Phase ... sodium crocetinate (TSC). In,addition, the company announced the ... of which will support the company,s overall growth,and ...

... accompanies the condition, study finds , , FRIDAY, Sept. ... whose painful illness prompts depression, relief may come ... embraced by millions around the world: meditation. , ... techniques helped patients shave as much as one-third ...

Other Medicine News:Health News:FDA Cracks Down on Unapproved Cough Medicines 2 Health News:FDA Cracks Down on Unapproved Cough Medicines 3 Health News:FDA Cracks Down on Unapproved Cough Medicines 4 Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 2 Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 3 Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 4 Health News:Rice unveils $100 million initiative for world health technology 2 Health News:Rice unveils $100 million initiative for world health technology 3 Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 2 Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 3 Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 4 Health News:Meditation May Help Rheumatoid Arthritis Sufferers 2 Health News:Meditation May Help Rheumatoid Arthritis Sufferers 3 Health News:Meditation May Help Rheumatoid Arthritis Sufferers 4

FDA Cracks Down on Unapproved Cough Medicines SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia Occupational therapy is an effective way of improving the daily life of stroke patients Rice unveils $100 million initiative for world health technology Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement Meditation May Help Rheumatoid Arthritis Sufferers

(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...

(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...

(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...

Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3 Exposure to lead tobacco smoke raises risk of ADHD 10856 1 Exposure to lead tobacco smoke raises risk of ADHD 10856 2 Measuring and modeling blood flow in malaria 61892 1 Measuring and modeling blood flow in malaria 61892 2

[0] U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter [0] Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts [0] FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels

... Fisher,Scientific Inc. (NYSE: TMO ), the world ... U.S. Food and Drug Administration (FDA) clearance for,Spectra(TM) ... aureus (MRSA), more commonly known as the "superbug." ... MRSA,screening, Spectra provides accurate results within 24 hours. ...

... Merck to Conduct Preclinical Proof-of-Principle Studies -, ... IOMI ) today announced that it has ... conduct proof-of-principle preclinical studies,evaluating the use of the ... option to negotiate an exclusive license. These,preclinical proof-of-principle ...

Other Medicine Technology:Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 2 Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 3 Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 4 Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2 Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3

Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch

The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....

Steroid eluting pacemaker leads...

The Medtronic Model 6495 bipolar coaxial temporary pacing lead is designed to provide the advantages of bipolar technology based on the sensing and pacing capabilities of the Medtronic Model 6500 uni...

Medicine Products:

Fineline II Sterox Model 4456 Fineline II Sterox Model 4457 Sweet Picotip RX Bipolar Coaxial 6495

Santa Barbara Medical Innovations Sponsors 2009 Microsoft Alumni Foundation Integral Fellows Awar...(d Chip Conk CEO of SBMI. “The numb...),Health